| Literature DB >> 25190155 |
Annelies Suetens1, Marjan Moreels2, Roel Quintens2, Els Soors2, Jasmine Buset2, Sabina Chiriotti3, Kevin Tabury2, Vincent Gregoire4, Sarah Baatout5.
Abstract
Hadrontherapy is an advanced form of radiotherapy that uses beams of charged particles (such as protons and carbon ions). Compared with conventional radiotherapy, the main advantages of carbon ion therapy are the precise absorbed dose localization, along with an increased relative biological effectiveness (RBE). This high ballistic accuracy of particle beams deposits the maximal dose to the tumor, while damage to the surrounding healthy tissue is limited. Currently, hadrontherapy is being used for the treatment of specific types of cancer. Previous in vitro studies have shown that, under certain circumstances, exposure to charged particles may inhibit cell motility and migration. In the present study, we investigated the expression of four motility-related genes in prostate (PC3) and colon (Caco-2) cancer cell lines after exposure to different radiation types. Cells were irradiated with various absorbed doses (0, 0.5 and 2 Gy) of accelerated (13)C-ions at the GANIL facility (Caen, France) or with X-rays. Clonogenic assays were performed to determine the RBE. RT-qPCR analysis showed dose- and time-dependent changes in the expression of CCDC88A, FN1, MYH9 and ROCK1 in both cell lines. However, whereas in PC3 cells the response to carbon ion irradiation was enhanced compared with X-irradiation, the effect was the opposite in Caco-2 cells, indicating cell-type-specific responses to the different radiation types.Entities:
Keywords: Caco-2 colon adenocarcinoma; PC3 prostate adenocarcinoma; carbon ion irradiation; colony survival assay; gene expression; motility genes
Mesh:
Substances:
Year: 2014 PMID: 25190155 PMCID: PMC4572596 DOI: 10.1093/jrr/rru070
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
List of Applied Biosystems assays used
| Gene symbol | Gene name | Assay ID | Ref seq | Exon boundary | Measured efficiency |
|---|---|---|---|---|---|
| FN1 | Fibronectin 1 | Hs01549967_m1 | NM_002026.2; | 3–4 | 1.98 |
| MYH9 | Myosin; heavy chain 9; non-muscle | Hs01066369_m1 | NM_002473.4 | 23–24 | 1.96 |
| CCDC88A | Coiled-coil domain containing 88A | Hs01559766_m1 | NM_001135597.1 | 18–19 | 1.98 |
| ROCK1 | Rho-associated; coiled-coil containing protein kinase 1 | Hs01127714_mH | NM_005406.2 | 4–5 | 1.99 |
| B2M | Beta-2-microglobulin | Hs00984230_m1 | NM_004048.2 | 3–4 | 2.05 |
Fig. 1.Colony survival assay of PC3 and Caco-2 cells exposed to carbon ion or X-irradiation. (A–B) Survival fraction of PC3 (A) and Caco-2 (B) cells calculated using conventional clonogenic assays. The linear quadratic model was applied to experimental data. (C) Surviving fractions of clonogenic cells exposed to 2 Gy carbon ion or X-irradiation.
Fig. 2.Relative gene expression changes of four motility genes in PC3 cells at 2 h, 8 h and 24 h after carbon ion (left column) and X-irradiation (right column). Log2(ratio) of the expression of CCDC88A after carbon ion (A) and X-irradiation (B), FN1 expression after carbon ion (C) and X-irradiation (D), MYH9 expression after carbon ion (E) and X-irradiation (F) and ROCK1 expression after carbon ion (G) and X-irradiation (H) is presented. *marks significantly altered gene expression compared to CTRL samples (P-value ≤ 0.05) based on one-tailed Mann Whitney tests.
Fig. 3.Relative gene expression changes of four motility genes in Caco-2 cells at 2 h, 8 h and 24 h after carbon ion (left column) and X-irradiation (right column). Log2(ratio) of the expression of CCDC88A after carbon ion (A) and X-irradiation (B), FN1 expression after carbon ion (C) and X-irradiation (D), MYH9 expression after carbon ion (E) and X-irradiation (F) and ROCK1 expression after carbon ion (G) and X-irradiation (H) is presented. *marks significantly altered gene expression compared to CTRL samples (P-value ≤ 0.05) based on one-tailed Mann Whitney tests.